However, tumor burden alone was not sufficient to explain the higher T790M abundance in patients in the OF group compared to those in the CF and BF groups because T790M abundance is calculated from the ratio of T790M mutation to total EGFR copy number. This evidence concerns the gene EGFR and neoplasm.